Case report: Exploring efficacy of tofacitinib in modulating interferon response in five case of anti-MDA5+ dermatomyositis with interstitial lung disease
A case report highlights the challenges faced in managing a 66-year-old Chinese woman diagnosed with anti-MDA5 antibody-positive dermatomyositis (MDA5-DM) complicated by rapidly progressive interstitial lung disease (RP-ILD). Despite aggressive therapeutic interventions, her condition rapidly deteri...
Saved in:
| Main Authors: | Jie Zhao, Yan Bao, Ying Gao, Keliang Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1515602/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case report: Successful treatment of anti‐MDA5‐positive to negative dermatomyositis‐associated interstitial lung disease with the JAK inhibitor tofacitinib
by: Zong Jiang, et al.
Published: (2023-06-01) -
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib
by: Valentina Natoli, et al.
Published: (2025-02-01) -
Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis
by: Chao Sun, et al.
Published: (2025-07-01) -
Anti–Melanoma Differentiation Associated Gene 5 (MDA 5) Dermatomyositis Complicated by Spontaneous Pneumomediastinum: A Case Report From South Africa
by: M. Myburgh
Published: (2024-11-01) -
Dysregulated type I/III interferon system in circulation from patients with anti-MDA5-positive dermatomyositis
by: Akira Yoshida, et al.
Published: (2025-07-01)